| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 25 | 2026 | 629 | 4.280 |
Why?
|
| Sinus Thrombosis, Intracranial | 4 | 2024 | 50 | 2.360 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 10 | 2026 | 286 | 2.260 |
Why?
|
| Microcephaly | 14 | 2026 | 347 | 2.020 |
Why?
|
| Homozygote | 16 | 2026 | 533 | 1.970 |
Why?
|
| Phenotype | 40 | 2026 | 4497 | 1.790 |
Why?
|
| Rett Syndrome | 5 | 2025 | 231 | 1.710 |
Why?
|
| DNA Copy Number Variations | 15 | 2024 | 1029 | 1.520 |
Why?
|
| Pedigree | 35 | 2026 | 1677 | 1.500 |
Why?
|
| Mutation | 38 | 2026 | 6099 | 1.390 |
Why?
|
| Intellectual Disability | 17 | 2026 | 1089 | 1.370 |
Why?
|
| Charcot-Marie-Tooth Disease | 6 | 2023 | 227 | 1.220 |
Why?
|
| Alleles | 19 | 2026 | 1673 | 1.090 |
Why?
|
| Child, Preschool | 44 | 2026 | 15110 | 1.020 |
Why?
|
| Zebrafish | 10 | 2025 | 418 | 1.000 |
Why?
|
| Metalloendopeptidases | 1 | 2026 | 101 | 0.910 |
Why?
|
| Accidents, Occupational | 1 | 2025 | 9 | 0.910 |
Why?
|
| Ships | 1 | 2025 | 7 | 0.910 |
Why?
|
| Occupational Injuries | 1 | 2025 | 11 | 0.900 |
Why?
|
| Child | 49 | 2026 | 26341 | 0.890 |
Why?
|
| Arthrogryposis | 3 | 2022 | 37 | 0.880 |
Why?
|
| Nervous System Malformations | 6 | 2024 | 135 | 0.880 |
Why?
|
| Genomics | 6 | 2022 | 1621 | 0.870 |
Why?
|
| Mutation, Missense | 9 | 2025 | 919 | 0.840 |
Why?
|
| Exome | 16 | 2020 | 1061 | 0.820 |
Why?
|
| Developmental Disabilities | 7 | 2026 | 781 | 0.810 |
Why?
|
| Humans | 121 | 2026 | 131163 | 0.810 |
Why?
|
| Infant | 30 | 2026 | 13352 | 0.760 |
Why?
|
| Male | 74 | 2026 | 64957 | 0.750 |
Why?
|
| Nuclear Proteins | 6 | 2024 | 1211 | 0.730 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2022 | 7 | 0.720 |
Why?
|
| Female | 70 | 2026 | 70963 | 0.680 |
Why?
|
| Nerve Tissue Proteins | 6 | 2026 | 1075 | 0.650 |
Why?
|
| DNA Replication | 2 | 2013 | 355 | 0.640 |
Why?
|
| Membrane Proteins | 8 | 2024 | 1590 | 0.640 |
Why?
|
| Adolescent | 35 | 2026 | 20987 | 0.630 |
Why?
|
| Brain | 8 | 2026 | 3175 | 0.620 |
Why?
|
| Genetic Association Studies | 7 | 2025 | 819 | 0.620 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2026 | 3436 | 0.600 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 343 | 0.590 |
Why?
|
| Gene Rearrangement | 4 | 2021 | 323 | 0.590 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 405 | 0.580 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 177 | 0.580 |
Why?
|
| Turkey | 6 | 2025 | 69 | 0.570 |
Why?
|
| De Lange Syndrome | 4 | 2018 | 44 | 0.570 |
Why?
|
| Gene Duplication | 7 | 2024 | 358 | 0.550 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 176 | 0.540 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 238 | 0.530 |
Why?
|
| Genetic Markers | 1 | 2019 | 587 | 0.520 |
Why?
|
| Scoliosis | 4 | 2020 | 147 | 0.510 |
Why?
|
| Mosaicism | 3 | 2026 | 248 | 0.510 |
Why?
|
| Loss of Heterozygosity | 3 | 2021 | 123 | 0.500 |
Why?
|
| Parents | 2 | 2024 | 1128 | 0.500 |
Why?
|
| Vesicular Transport Proteins | 4 | 2024 | 138 | 0.490 |
Why?
|
| Brain Diseases | 3 | 2024 | 299 | 0.480 |
Why?
|
| Movement Disorders | 3 | 2024 | 218 | 0.480 |
Why?
|
| Dystonia | 3 | 2023 | 165 | 0.480 |
Why?
|
| Stroke | 2 | 2022 | 1061 | 0.480 |
Why?
|
| Caregivers | 1 | 2022 | 598 | 0.470 |
Why?
|
| Myelin Proteins | 2 | 2015 | 78 | 0.470 |
Why?
|
| Adult | 25 | 2025 | 31282 | 0.470 |
Why?
|
| Genome, Human | 6 | 2026 | 1321 | 0.470 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2023 | 588 | 0.470 |
Why?
|
| Genetic Variation | 8 | 2026 | 1559 | 0.460 |
Why?
|
| Polyneuropathies | 1 | 2015 | 33 | 0.450 |
Why?
|
| Epilepsy | 7 | 2022 | 876 | 0.440 |
Why?
|
| Animals | 36 | 2026 | 33912 | 0.430 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 155 | 0.420 |
Why?
|
| Neoplasm Proteins | 4 | 2026 | 680 | 0.410 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 3 | 2023 | 25 | 0.410 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 68 | 0.410 |
Why?
|
| Abnormalities, Multiple | 4 | 2020 | 963 | 0.410 |
Why?
|
| Congenital Disorders of Glycosylation | 2 | 2025 | 50 | 0.400 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 283 | 0.400 |
Why?
|
| DNA Breaks | 1 | 2013 | 25 | 0.400 |
Why?
|
| Proteins | 4 | 2016 | 1006 | 0.400 |
Why?
|
| Infant, Newborn | 9 | 2026 | 8635 | 0.390 |
Why?
|
| Loss of Function Mutation | 3 | 2024 | 177 | 0.380 |
Why?
|
| Trichothiodystrophy Syndromes | 1 | 2012 | 1 | 0.380 |
Why?
|
| Genetic Heterogeneity | 3 | 2024 | 132 | 0.380 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2012 | 19 | 0.380 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2015 | 130 | 0.360 |
Why?
|
| Quality of Life | 1 | 2022 | 2082 | 0.360 |
Why?
|
| Frameshift Mutation | 3 | 2026 | 200 | 0.350 |
Why?
|
| White Matter | 2 | 2026 | 219 | 0.350 |
Why?
|
| Cell Cycle Proteins | 6 | 2019 | 710 | 0.340 |
Why?
|
| Lissencephaly | 2 | 2022 | 10 | 0.340 |
Why?
|
| Constipation | 2 | 2023 | 131 | 0.340 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 126 | 0.340 |
Why?
|
| Comparative Genomic Hybridization | 7 | 2024 | 566 | 0.330 |
Why?
|
| Epilepsy, Generalized | 2 | 2022 | 63 | 0.330 |
Why?
|
| Growth Disorders | 3 | 2020 | 181 | 0.320 |
Why?
|
| Chromosomes, Human, X | 4 | 2026 | 155 | 0.320 |
Why?
|
| Cerebellar Diseases | 3 | 2020 | 78 | 0.320 |
Why?
|
| Autistic Disorder | 2 | 2026 | 398 | 0.320 |
Why?
|
| RNA, Transfer | 2 | 2025 | 57 | 0.320 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 422 | 0.320 |
Why?
|
| Cohort Studies | 10 | 2024 | 5063 | 0.320 |
Why?
|
| Neuromuscular Diseases | 2 | 2020 | 45 | 0.310 |
Why?
|
| DNA Repair | 1 | 2013 | 571 | 0.310 |
Why?
|
| Young Adult | 12 | 2025 | 10103 | 0.310 |
Why?
|
| Anticoagulants | 3 | 2024 | 605 | 0.310 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2011 | 750 | 0.290 |
Why?
|
| Repressor Proteins | 4 | 2026 | 760 | 0.280 |
Why?
|
| Head and Neck Neoplasms | 3 | 2008 | 638 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2008 | 94 | 0.270 |
Why?
|
| Atrophy | 5 | 2020 | 247 | 0.260 |
Why?
|
| HEK293 Cells | 3 | 2026 | 801 | 0.260 |
Why?
|
| Neurons | 4 | 2026 | 1979 | 0.250 |
Why?
|
| Eczema | 2 | 2020 | 35 | 0.250 |
Why?
|
| Mice | 20 | 2024 | 18301 | 0.240 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2023 | 248 | 0.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2024 | 889 | 0.240 |
Why?
|
| Inheritance Patterns | 2 | 2019 | 127 | 0.240 |
Why?
|
| Base Sequence | 7 | 2017 | 2730 | 0.240 |
Why?
|
| Haplotypes | 2 | 2026 | 519 | 0.240 |
Why?
|
| Calcium Channels | 2 | 2019 | 143 | 0.240 |
Why?
|
| RNA, Small Nuclear | 1 | 2026 | 49 | 0.230 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 4066 | 0.230 |
Why?
|
| Muscular Dystrophies | 2 | 2023 | 51 | 0.230 |
Why?
|
| Zebrafish Proteins | 2 | 2025 | 133 | 0.230 |
Why?
|
| RNA-Binding Proteins | 3 | 2026 | 533 | 0.230 |
Why?
|
| RNA, Untranslated | 1 | 2026 | 109 | 0.230 |
Why?
|
| Siblings | 2 | 2024 | 201 | 0.230 |
Why?
|
| tRNA Methyltransferases | 1 | 2025 | 5 | 0.220 |
Why?
|
| Bardet-Biedl Syndrome | 2 | 2016 | 37 | 0.220 |
Why?
|
| Occupational Health | 1 | 2025 | 43 | 0.220 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2018 | 209 | 0.220 |
Why?
|
| Glucosyltransferases | 1 | 2025 | 44 | 0.220 |
Why?
|
| Spindle Apparatus | 1 | 2025 | 50 | 0.220 |
Why?
|
| Drosophila melanogaster | 2 | 2024 | 789 | 0.220 |
Why?
|
| Retrospective Studies | 8 | 2024 | 17753 | 0.210 |
Why?
|
| Methyltransferases | 1 | 2025 | 78 | 0.210 |
Why?
|
| Safety Management | 1 | 2025 | 111 | 0.210 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 468 | 0.210 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2022 | 79 | 0.210 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 70 | 0.210 |
Why?
|
| Genes, Dominant | 2 | 2024 | 242 | 0.210 |
Why?
|
| Heterozygote | 7 | 2018 | 737 | 0.200 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 5196 | 0.200 |
Why?
|
| Fibroblasts | 4 | 2023 | 849 | 0.200 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 395 | 0.200 |
Why?
|
| Genotype | 5 | 2024 | 2595 | 0.200 |
Why?
|
| Genes, Recessive | 5 | 2026 | 193 | 0.200 |
Why?
|
| Cerebellum | 4 | 2021 | 441 | 0.200 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 49 | 0.200 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 180 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2024 | 241 | 0.190 |
Why?
|
| Biological Variation, Population | 2 | 2024 | 27 | 0.190 |
Why?
|
| Neural Stem Cells | 1 | 2024 | 133 | 0.190 |
Why?
|
| Cell Division | 1 | 2024 | 718 | 0.190 |
Why?
|
| Urogenital Abnormalities | 2 | 2022 | 155 | 0.190 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2022 | 14 | 0.190 |
Why?
|
| Eye Abnormalities | 2 | 2021 | 105 | 0.190 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.190 |
Why?
|
| Family | 5 | 2020 | 589 | 0.190 |
Why?
|
| Contracture | 1 | 2022 | 26 | 0.180 |
Why?
|
| Apyrase | 1 | 2022 | 23 | 0.180 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 262 | 0.180 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2022 | 12 | 0.180 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.180 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 30 | 0.180 |
Why?
|
| Dystonic Disorders | 1 | 2023 | 92 | 0.180 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 68 | 0.180 |
Why?
|
| Muscular Diseases | 1 | 2023 | 118 | 0.180 |
Why?
|
| Cranial Sinuses | 1 | 2022 | 16 | 0.180 |
Why?
|
| Neural Conduction | 3 | 2020 | 82 | 0.180 |
Why?
|
| Electroencephalography | 2 | 2025 | 863 | 0.180 |
Why?
|
| Software | 2 | 2024 | 733 | 0.180 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 130 | 0.180 |
Why?
|
| Decompressive Craniectomy | 1 | 2022 | 14 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 223 | 0.180 |
Why?
|
| Sequence Deletion | 4 | 2021 | 516 | 0.180 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 653 | 0.180 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.170 |
Why?
|
| Brain Edema | 1 | 2022 | 66 | 0.170 |
Why?
|
| Facies | 4 | 2020 | 157 | 0.170 |
Why?
|
| Syndrome | 5 | 2023 | 1155 | 0.170 |
Why?
|
| MELAS Syndrome | 1 | 2022 | 39 | 0.170 |
Why?
|
| Urinary Tract | 1 | 2022 | 55 | 0.170 |
Why?
|
| T-Box Domain Proteins | 2 | 2020 | 123 | 0.170 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2021 | 5 | 0.170 |
Why?
|
| Chromosome Duplication | 1 | 2021 | 146 | 0.160 |
Why?
|
| Alu Elements | 1 | 2021 | 66 | 0.160 |
Why?
|
| Mediator Complex | 1 | 2021 | 62 | 0.160 |
Why?
|
| Symporters | 1 | 2021 | 80 | 0.160 |
Why?
|
| Fibrillar Collagens | 1 | 2020 | 14 | 0.160 |
Why?
|
| Founder Effect | 1 | 2020 | 32 | 0.160 |
Why?
|
| Molecular Sequence Data | 6 | 2016 | 3464 | 0.160 |
Why?
|
| Chromosome Breakpoints | 3 | 2019 | 81 | 0.160 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 86 | 0.160 |
Why?
|
| Hip Dislocation | 1 | 2020 | 31 | 0.150 |
Why?
|
| Netrins | 1 | 2019 | 5 | 0.150 |
Why?
|
| Psychometrics | 1 | 2024 | 678 | 0.150 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 47 | 0.150 |
Why?
|
| Ribosomes | 1 | 2020 | 123 | 0.150 |
Why?
|
| Encephalitis | 1 | 2021 | 122 | 0.150 |
Why?
|
| Cytokines | 1 | 2026 | 1339 | 0.150 |
Why?
|
| Muscle Hypotonia | 2 | 2022 | 194 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 2904 | 0.150 |
Why?
|
| Alopecia | 2 | 2023 | 41 | 0.150 |
Why?
|
| Connectin | 1 | 2019 | 30 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 259 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2022 | 209 | 0.150 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 102 | 0.150 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 158 | 0.150 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 110 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 4 | 2024 | 1692 | 0.140 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 50 | 0.140 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 182 | 0.140 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 61 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 251 | 0.130 |
Why?
|
| Exons | 2 | 2017 | 759 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2024 | 2833 | 0.130 |
Why?
|
| Fibromatosis, Gingival | 1 | 2017 | 4 | 0.130 |
Why?
|
| Spasms, Infantile | 1 | 2019 | 166 | 0.130 |
Why?
|
| Naegleria fowleri | 1 | 2017 | 4 | 0.130 |
Why?
|
| Central Nervous System Protozoal Infections | 1 | 2017 | 5 | 0.130 |
Why?
|
| Gene Dosage | 1 | 2019 | 435 | 0.130 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 420 | 0.130 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 242 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 895 | 0.120 |
Why?
|
| Consanguinity | 3 | 2022 | 115 | 0.120 |
Why?
|
| Autophagy | 1 | 2020 | 417 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 744 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 2395 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2019 | 330 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2020 | 582 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 619 | 0.120 |
Why?
|
| Myelin P0 Protein | 1 | 2015 | 26 | 0.120 |
Why?
|
| Genetic Load | 1 | 2015 | 5 | 0.120 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2015 | 10 | 0.110 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2015 | 6 | 0.110 |
Why?
|
| Chromosome Segregation | 3 | 2025 | 68 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 100 | 0.110 |
Why?
|
| Anxiety | 1 | 2022 | 1014 | 0.110 |
Why?
|
| Hypogonadism | 2 | 2019 | 299 | 0.110 |
Why?
|
| Gestational Age | 1 | 2019 | 1224 | 0.110 |
Why?
|
| Penetrance | 2 | 2015 | 107 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 982 | 0.110 |
Why?
|
| Hypopituitarism | 1 | 2015 | 19 | 0.110 |
Why?
|
| Motor Neurons | 1 | 2015 | 131 | 0.110 |
Why?
|
| Pituitary Gland | 1 | 2015 | 74 | 0.110 |
Why?
|
| Cell Movement | 3 | 2026 | 876 | 0.110 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2014 | 16 | 0.110 |
Why?
|
| Prevalence | 1 | 2021 | 2701 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 2323 | 0.110 |
Why?
|
| Anodontia | 1 | 2014 | 33 | 0.100 |
Why?
|
| Drosophila | 3 | 2024 | 739 | 0.100 |
Why?
|
| Glycosylation | 2 | 2025 | 127 | 0.100 |
Why?
|
| Phosphotransferases | 1 | 2014 | 33 | 0.100 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 136 | 0.100 |
Why?
|
| Anophthalmos | 1 | 2014 | 23 | 0.100 |
Why?
|
| X Chromosome Inactivation | 3 | 2021 | 59 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2025 | 6459 | 0.100 |
Why?
|
| Refsum Disease | 1 | 2013 | 4 | 0.100 |
Why?
|
| Age of Onset | 1 | 2015 | 592 | 0.100 |
Why?
|
| DNA Mutational Analysis | 5 | 2014 | 775 | 0.100 |
Why?
|
| Drosophila Proteins | 3 | 2024 | 718 | 0.100 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2013 | 38 | 0.100 |
Why?
|
| Middle Aged | 7 | 2024 | 28601 | 0.100 |
Why?
|
| Armadillo Domain Proteins | 1 | 2013 | 7 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2015 | 197 | 0.100 |
Why?
|
| Dyneins | 1 | 2013 | 15 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2015 | 4686 | 0.100 |
Why?
|
| Kartagener Syndrome | 1 | 2013 | 12 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 98 | 0.100 |
Why?
|
| Gene Frequency | 3 | 2020 | 729 | 0.100 |
Why?
|
| Disease | 1 | 2014 | 121 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 1373 | 0.100 |
Why?
|
| Depression | 1 | 2022 | 1320 | 0.100 |
Why?
|
| Curcumin | 1 | 2013 | 41 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 373 | 0.100 |
Why?
|
| Genomic Structural Variation | 2 | 2024 | 97 | 0.100 |
Why?
|
| Body Patterning | 1 | 2013 | 122 | 0.100 |
Why?
|
| Respiratory System | 1 | 2013 | 94 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2014 | 221 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 491 | 0.090 |
Why?
|
| Protein Conformation | 2 | 2014 | 732 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2014 | 423 | 0.090 |
Why?
|
| Cilia | 1 | 2013 | 74 | 0.090 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 128 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 289 | 0.090 |
Why?
|
| Obesity | 1 | 2024 | 2426 | 0.090 |
Why?
|
| Chromosome Mapping | 2 | 2019 | 1046 | 0.090 |
Why?
|
| Gene Order | 1 | 2012 | 80 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 3763 | 0.090 |
Why?
|
| Mammals | 2 | 2023 | 253 | 0.090 |
Why?
|
| IgA Deficiency | 1 | 2011 | 5 | 0.090 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2011 | 22 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 292 | 0.080 |
Why?
|
| Rare Diseases | 2 | 2024 | 210 | 0.080 |
Why?
|
| Tubulin | 2 | 2022 | 76 | 0.080 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2010 | 5 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2026 | 1939 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2008 | 200 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2596 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2022 | 2406 | 0.080 |
Why?
|
| DNA Helicases | 2 | 2023 | 239 | 0.080 |
Why?
|
| Risk Factors | 1 | 2024 | 11074 | 0.070 |
Why?
|
| Axons | 2 | 2022 | 386 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2022 | 3819 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2012 | 767 | 0.070 |
Why?
|
| Kidney | 3 | 2022 | 1282 | 0.070 |
Why?
|
| Receptor, EphA2 | 1 | 2008 | 25 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 1103 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 204 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4697 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2014 | 1106 | 0.070 |
Why?
|
| Cell Line | 2 | 2023 | 2552 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2010 | 1064 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 388 | 0.060 |
Why?
|
| Spine | 2 | 2019 | 153 | 0.060 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2026 | 25 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 645 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2008 | 2550 | 0.060 |
Why?
|
| Gastrulation | 2 | 2016 | 26 | 0.060 |
Why?
|
| Centrosome | 1 | 2025 | 28 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2025 | 66 | 0.050 |
Why?
|
| Ethanolamine | 1 | 2024 | 8 | 0.050 |
Why?
|
| Seizures | 2 | 2021 | 890 | 0.050 |
Why?
|
| Databases, Genetic | 2 | 2019 | 504 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 47 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 555 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2007 | 697 | 0.050 |
Why?
|
| R-SNARE Proteins | 1 | 2024 | 21 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2024 | 95 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2025 | 208 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 258 | 0.050 |
Why?
|
| Sensation Disorders | 1 | 2024 | 25 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 117 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2026 | 362 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2024 | 101 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2026 | 346 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 14 | 0.050 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 1833 | 0.050 |
Why?
|
| Mevalonic Acid | 1 | 2023 | 18 | 0.050 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2023 | 29 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 138 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2023 | 40 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 24 | 0.050 |
Why?
|
| Survival Rate | 1 | 2008 | 2114 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2026 | 248 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2024 | 194 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 25 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 93 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 34 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2023 | 105 | 0.050 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 10 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 17 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Tremor | 1 | 2024 | 127 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 79 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 172 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2024 | 206 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 24 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 160 | 0.040 |
Why?
|
| Histidine | 1 | 2022 | 69 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2022 | 128 | 0.040 |
Why?
|
| Egypt | 1 | 2021 | 33 | 0.040 |
Why?
|
| Nitrogen | 1 | 2022 | 120 | 0.040 |
Why?
|
| Paraplegia | 1 | 2022 | 84 | 0.040 |
Why?
|
| Prognosis | 2 | 2008 | 4886 | 0.040 |
Why?
|
| Calpain | 1 | 2021 | 42 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2019 | 749 | 0.040 |
Why?
|
| Glycogen | 1 | 2021 | 50 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2008 | 3359 | 0.040 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 5 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 251 | 0.040 |
Why?
|
| Glutamine | 1 | 2022 | 200 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 54 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.040 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 26 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 429 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 2026 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 134 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 235 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 222 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 354 | 0.040 |
Why?
|
| Bone Development | 1 | 2020 | 58 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2021 | 222 | 0.040 |
Why?
|
| Quadriplegia | 1 | 2020 | 34 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2024 | 385 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 84 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 344 | 0.040 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2019 | 11 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2020 | 92 | 0.040 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 51 | 0.040 |
Why?
|
| Cataract | 1 | 2021 | 153 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1481 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 523 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 166 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1586 | 0.040 |
Why?
|
| Deafness | 1 | 2020 | 77 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 200 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 326 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 451 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2026 | 1077 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2021 | 363 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 154 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 285 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 133 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 211 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2019 | 152 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 232 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 2019 | 61 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 573 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 401 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 378 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 303 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 254 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 136 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 52 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2018 | 93 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 317 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 157 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 399 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4738 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 445 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 3360 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3370 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1928 | 0.030 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 22 | 0.030 |
Why?
|
| Apoptosis | 1 | 2022 | 1827 | 0.030 |
Why?
|
| Myelin P2 Protein | 1 | 2015 | 10 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1356 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2015 | 38 | 0.030 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2015 | 18 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 214 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 981 | 0.030 |
Why?
|
| Exonucleases | 1 | 2015 | 27 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 30 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 1801 | 0.030 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 597 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 49 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 26 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3829 | 0.030 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2014 | 26 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 81 | 0.030 |
Why?
|
| Cerebrum | 1 | 2014 | 32 | 0.030 |
Why?
|
| Microphthalmos | 1 | 2014 | 54 | 0.030 |
Why?
|
| Coloboma | 1 | 2014 | 41 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 167 | 0.020 |
Why?
|
| Axoneme | 1 | 2013 | 7 | 0.020 |
Why?
|
| Inflammation | 1 | 2021 | 1489 | 0.020 |
Why?
|
| X Chromosome | 1 | 2014 | 327 | 0.020 |
Why?
|
| Endoribonucleases | 1 | 2014 | 87 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2013 | 57 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2018 | 993 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 72 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 743 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2013 | 66 | 0.020 |
Why?
|
| Aged | 2 | 2008 | 21025 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 356 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 716 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 269 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2014 | 353 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 154 | 0.020 |
Why?
|
| Retina | 1 | 2015 | 425 | 0.020 |
Why?
|
| Cleft Palate | 1 | 2015 | 221 | 0.020 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2011 | 28 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 352 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 69 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 950 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2007 | 208 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 481 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 713 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 484 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 1483 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 1336 | 0.010 |
Why?
|
| United States | 1 | 2019 | 12072 | 0.010 |
Why?
|